Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Affiliations

• ¹ State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
• ² Institute of Urinary Surgery, Xijing Hospital, Fourth Military Medical, University, Xi'an, 710032, People's Republic of China.
• ³ Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
• ⁴ Infection and Immunity Program, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.
• ⁵ Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
• ⁶ School of Pharmacy, China Medical University, Liaoning, 110122, China.
• ⁷ Department of Pharmacology, Xi'an Medical University, Xi'an, 710021, People's Republic of China.
• ⁸ Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China. caoxr528@sohu.com.
• ⁹ State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China. luzfliuq@fmmu.edu.cn.